|
|
| Phases of Development | Phase I | Phase I/II | Phase II | Phase III | Approved | Marketed |
|---|
| Autoimmune | 0 | 0 | 6 | 2 | 1 | 0 | | Cancer | 0 | 0 | 1 | 0 | 0 | 0 | | Hematology | 0 | 1 | 2 | 0 | 0 | 1 | | Inflammation | 1 | 0 | 0 | 0 | 0 | 0 | | Ophthalmic | 0 | 0 | 1 | 0 | 0 | 0 | | Renal | 0 | 0 | 1 | 0 | 0 | 0 |
|
|
Products Targeting Janus kinase-1 (JAK-1)